U.S. Oil and Gas Stock News

NasdaqGM:GPCR
NasdaqGM:GPCRPharmaceuticals

Did New Shelf Registration and Oral GLP-1 Progress Just Shift Structure Therapeutics' (GPCR) Investment Narrative?

Structure Therapeutics Inc. recently filed a US$235.64 million shelf registration for 3,541,890 American Depositary Shares tied to its employee stock ownership plan, following earlier Phase 2 data showing significant weight loss with its oral GLP-1 candidate aleniglipron. These capital markets moves come on the heels of a large hedge fund increasing its position and a very large public offering, underscoring institutional interest in the company’s obesity-focused pipeline. Against this...
NasdaqGM:AXSM
NasdaqGM:AXSMPharmaceuticals

Axsome Explores Solriamfetol In Phase 3 CLARITY Trial For MDD Subset

Axsome Therapeutics (NasdaqGM: AXSM) has started the CLARITY Phase 3 trial of solriamfetol in major depressive disorder with excessive daytime sleepiness. The trial focuses on a group of MDD patients who experience excessive daytime sleepiness, for which no approved treatments are currently available. This study expands Axsome's clinical program into an area of unmet medical need. Axsome Therapeutics, listed on the NasdaqGM under the ticker AXSM, develops therapies for central nervous...
NYSE:UWMC
NYSE:UWMCDiversified Financial

UWM Holdings Reshapes Mortgage Model With Two Harbors Deal And Tech Push

UWM Holdings (NYSE:UWMC) has entered into a definitive agreement to acquire Two Harbors Investment Corp., aiming to expand its mortgage servicing footprint. The company is rolling out new technology tools, including an AI powered income calculator, to streamline underwriting decisions. UWM is also partnering with BILT on a rewards offering that ties mortgage activity to loyalty benefits for customers. For investors watching NYSE:UWMC at a current share price of $4.55, these moves come after...
NasdaqGM:APPF
NasdaqGM:APPFSoftware

How AppFolio’s New Tightly Covenanted Credit Facility (APPF) Has Changed Its Investment Story

Earlier this week, AppFolio, Inc. entered into a US$150,000,000 senior secured revolving credit facility with PNC Bank that includes stringent covenants limiting additional borrowing, major investments, and certain capital return activities. While this facility bolsters liquidity, its tight restrictions introduce new constraints on how AppFolio can finance growth initiatives and manage its balance sheet over time. Next, we’ll examine how this new, tightly covenanted credit facility may alter...
NYSE:SPXC
NYSE:SPXCMachinery

SPX Technologies Reshapes Business With Deals Earnings And Shifting Ownership

SPX Technologies is pursuing an acquisition-led expansion and investing heavily in capacity, including in data center infrastructure. The company recently reported record earnings that align with this repositioning of its business mix. At the same time, insider selling and shifts in institutional ownership are reshaping who holds NYSE:SPXC shares. For investors, this mix of corporate activity and ownership changes makes NYSE:SPXC a stock to watch. The shares recently closed at $231.59, with...
NasdaqGS:CLMT
NasdaqGS:CLMTOil and Gas

Calumet (CLMT) Valuation Revisited After Strong Multi Month Share Price Rally

Calumet (CLMT) has drawn investor attention after recent trading, with the shares closing at $30.22 and posting strong gains over the past month and past 3 months. That move raises fresh questions about valuation and risk. See our latest analysis for Calumet. The recent 36.56% 1 month share price return and 56.58% 3 month share price return, alongside a 1 year total shareholder return of 101.74%, indicate that momentum has been building rather than fading for Calumet. If this move in Calumet...
NasdaqGS:PZZA
NasdaqGS:PZZAHospitality

Papa Johns International PZZA Margin Compression Reinforces Bearish Cost Narrative In FY 2025 Results

Papa John's International FY 2025 Earnings Snapshot Papa John's International (PZZA) closed out FY 2025 with Q4 revenue of US$498.2 million and basic EPS of US$0.24, while trailing twelve month revenue came in at about US$2.1 billion with EPS of US$0.93. The company has seen quarterly revenue move from US$530.8 million in Q4 2024 to US$498.2 million in Q4 2025, with basic EPS shifting from US$0.45 to US$0.24 over the same period, and trailing net income excluding extra items sitting at...
NYSE:KRC
NYSE:KRCOffice REITs

Kilroy’s Board ESG Overhaul Might Change The Case For Investing In Kilroy Realty (KRC)

Kilroy Realty Corporation recently overhauled its board structure, appointing Gary Stevenson as Chair, reshuffling key committee leadership, adding two independent directors, and reallocating ESG and human capital oversight across existing committees as of February 24, 2026. The decision to disband the standalone Corporate Social Responsibility and Sustainability Committee and embed ESG and human capital oversight into core board committees signals a deeper integration of these priorities...
NYSE:CRCL
NYSE:CRCLSoftware

Is Circle Internet Group (CRCL) Pricing Reflecting Recent Stablecoin And Crypto Market Excitement?

If you are trying to figure out whether Circle Internet Group at US$87.21 is attractively priced or not, you are in the right place. This article is all about what that price could mean for long term investors. The stock has seen sharp recent moves, with a 40.8% return over the past 7 days, 24.7% over the last 30 days, and 4.5% year to date. These movements can change how the market views its potential and its risks. These swings are attracting attention as investors react to ongoing news...
NYSE:MCB
NYSE:MCBBanks

A Look At Metropolitan Bank Holding (MCB) Valuation After Recent Follow On Equity Offerings

Metropolitan Bank Holding (MCB) has completed and filed follow-on equity offerings totaling roughly US$353.5 million, issuing 2,100,000 common shares at US$85, a move that directly affects existing and prospective shareholders. See our latest analysis for Metropolitan Bank Holding. The follow on offerings come after a strong 1 year total shareholder return of 41.92% and a 3 year total shareholder return of 56.43%. However, recent momentum has cooled, with a 7 day share price return showing an...
NasdaqGS:NTRA
NasdaqGS:NTRABiotechs

Is It Time To Reassess Natera (NTRA) After Strong Multi Year Share Price Gains

If you are wondering whether Natera's current share price reflects its real value, you are not alone. This article will help you frame that question clearly. Natera's share price last closed at US$216.10, with a 7 day return of 0.1% decline, a 30 day return of 10.1% decline, a year to date return of 5.6% decline, and a 1 year return of 38.0%, alongside a very large 3 year return and a 111.6% return over 5 years. Recent headlines around Natera have kept the stock on many investors'...
NasdaqGS:DKNG
NasdaqGS:DKNGHospitality

Does DraftKings’ (DKNG) Expansion and Restructuring Strategy Reframe Its Long‑Term Profitability Narrative?

In recent weeks, DraftKings Inc. has gained approval to launch its online sportsbook in Arkansas on behalf of Southland Casino Hotel and rolled out its online sportsbook in Puerto Rico, while also progressing a workforce restructuring and facing a Massachusetts class action over a past "$1,000 Deposit Bonus" promotion. Together, these developments highlight a company simultaneously widening its regulated footprint, tightening its cost base, and confronting growing scrutiny over how it...
NasdaqGS:PTC
NasdaqGS:PTCSoftware

Will Cloud-Native Onshape MBD Make PTC's (PTC) Platform Central to the Product Data Workflow Narrative

On 26 February 2026, PTC Inc. released a fully cloud-native Model-Based Definition capability within its Onshape CAD and PDM platform, enabling engineers to embed manufacturing information directly into always up-to-date 3D models. This move positions Onshape as a more integrated, browser-accessible hub for product data, potentially simplifying collaboration across design, manufacturing, and quality teams. We’ll now examine how embedding manufacturing data directly into cloud-native 3D...
NasdaqGS:IONS
NasdaqGS:IONSBiotechs

A Look At Ionis Pharmaceuticals (IONS) Valuation After Strong One Year Returns And Large Estimated DCF Upside

Ionis Pharmaceuticals overview and recent share performance Ionis Pharmaceuticals (IONS) has drawn investor attention recently, with the share price closing at US$80.60 and showing mixed returns over the past week, month, past 3 months, and year to date. Over the past year, total return is 157.10%. The past 3 years and 5 years show total returns of 125.08% and 57.21% respectively, providing context for how the stock has behaved across different holding periods. See our latest analysis for...
NYSE:IVZ
NYSE:IVZCapital Markets

Invesco Expands Retirement Toolkit With New Real Estate Trust And ETFs

Invesco (NYSE:IVZ) has introduced the Invesco Core Plus Real Estate Trust, a collective investment trust aimed at expanding private real estate access for defined contribution retirement plans. The firm has also launched four fixed income ETFs designed to address changing investor needs around income, duration, and risk management. These product launches reflect Invesco's current focus on retirement solutions and income oriented tools within its broader asset management offering. Invesco,...
NasdaqGS:STBA
NasdaqGS:STBABanks

A Look At S&T Bancorp (STBA) Valuation As Shares Trade Near Analyst Fair Value Estimate

Event context and recent share performance S&T Bancorp (STBA) has recently drawn attention after its shares closed at US$43.97, with total return figures over the past year and past 3 months giving investors fresh context for assessing the regional bank. See our latest analysis for S&T Bancorp. While the 1-day share price return of 0.20% and 7-day share price return of 1.24% show some recent softness, the 30-day and 90-day share price returns of 4.42% and 11.37%, alongside a 1-year total...
NasdaqGS:MGNI
NasdaqGS:MGNIMedia

Magnite (MGNI) Net Margin Surge Challenges Bearish Earnings Narratives

Magnite (MGNI) closed out FY 2025 with Q4 revenue of US$205.4 million and basic EPS of US$0.86, capped by trailing 12 month EPS of US$1.01 that sits on trailing 12 month revenue of US$714.0 million. Over the past six quarters in this dataset, revenue has moved from US$162.0 million in Q3 2024 to US$205.4 million in Q4 2025, while quarterly EPS shifted from US$0.04 to US$0.86, creating a backdrop where margins have become a central focus for investors assessing the latest print. See our full...
NasdaqGM:FUTU
NasdaqGM:FUTUCapital Markets

What Futu Holdings (FUTU)'s Q4 2025 Results and Education Push Mean For Shareholders

Earlier in 2026, Futu Holdings announced that it would report its fourth-quarter and full-year 2025 results on March 12, 2026, before U.S. markets open, accompanied by a management earnings call and webcast. Alongside its earnings timetable, Futu’s moomoo platform has been promoting financial education through initiatives like the Student Stock Showdown, underscoring how its brokerage technology is also being used to build investing literacy among younger users. With stronger recent earnings...
NYSE:WSO
NYSE:WSOTrade Distributors

Dividend Hike Amid Softer Earnings Might Change The Case For Investing In Watsco (WSO)

In February 2026, Watsco, Inc. reported that its fourth-quarter 2025 sales fell to US$1,578.76 million and net income to US$71.75 million, and also approved a 10% increase in its annual dividend to US$13.20 per share for both Common and Class B shares. The combination of softer recent earnings and a higher dividend, underpinned by management’s emphasis on improved gross margins and a debt-free balance sheet, highlights how Watsco is prioritizing shareholder returns while contending with...
NasdaqGS:DFTX
NasdaqGS:DFTXPharmaceuticals

Is Rising 2025 Loss and Investor Outreach Altering The Investment Case For Definium Therapeutics (DFTX)?

Definium Therapeutics, Inc. reported full-year 2025 results on February 26, 2026, posting a wider net loss of US$183.79 million and basic and diluted loss per share from continuing operations of US$2.06, compared with US$108.68 million and US$1.54 a year earlier. This larger loss, alongside management’s recent participation in multiple healthcare investor conferences, highlights how the company is balancing capital-intensive late-stage clinical development with efforts to keep investors...
NYSE:BAP
NYSE:BAPBanks

Is It Time To Reassess Credicorp (NYSE:BAP) After Its Strong Multi Year Share Price Run?

If you are looking at Credicorp and wondering whether the current share price still reflects solid value, you are not alone. This article will walk through what the numbers actually say. The stock last closed at US$355.48, with returns of 1.7% over 7 days, a marginal 0.2% decline over 30 days, 24.1% year to date, 106.7% over 1 year and 183.7% over 5 years. This naturally raises questions about how much future upside or risk is already built in. Recent news coverage has focused on Credicorp's...
NYSE:ARLO
NYSE:ARLOElectronic

A Look At Arlo Technologies (ARLO) Valuation After Recent Share Price Volatility

Arlo Technologies (ARLO) has drawn fresh attention after recent trading left the stock up 3.6% over the past week, but down over the past month and past 3 months, prompting closer scrutiny from investors. See our latest analysis for Arlo Technologies. That recent 6.2% 7 day share price return comes after weaker momentum earlier in the year, with a 30 day share price return of 6.52% and year to date share price return of 6.73%. The 3 year total shareholder return is roughly 3.3x, which hints...
NasdaqGS:PCTY
NasdaqGS:PCTYProfessional Services

A Look At Paylocity (PCTY) Valuation After Q2 Beat And Raised 2026 Revenue Outlook

Paylocity Holding (PCTY) is in focus after second quarter results came in ahead of guidance, prompting higher revenue projections for fiscal 2026 and an updated outlook for total and recurring revenues. See our latest analysis for Paylocity Holding. The second quarter beat and upgraded fiscal 2026 revenue outlook arrive after a mixed share price run, with an 8.52% 1 day share price return and 6.59% 7 day share price return contrasting with a 19.95% 30 day share price decline and a 44.87% 1...
NYSE:YETI
NYSE:YETILeisure

Did YETI’s New CFO, Buybacks, and 2026 Guidance Just Shift YETI Holdings’ (YETI) Investment Narrative?

Earlier in February 2026, YETI Holdings appointed former Home Depot finance executive Scott Bomar as its new Chief Financial Officer, reported fourth-quarter and full-year 2025 results showing higher quarterly sales and earnings, issued 2026 sales growth guidance of 6% to 8%, and completed a US$497.72 million share repurchase program. These announcements highlight YETI’s focus on leadership refresh, disciplined capital returns through buybacks, and continued investment in product innovation...